We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$269M
AUM Growth
-$24.5M
Cap. Flow
-$35.3M
Cap. Flow %
-13.1%
Top 10 Hldgs %
26.19%
Holding
93
New
19
Increased
21
Reduced
26
Closed
25

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$6.83M
2
UHS icon
Universal Health Services
UHS
+$6.41M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.69M
4
VTRS icon
Viatris
VTRS
+$4.59M
5
JNJ icon
Johnson & Johnson
JNJ
+$4.18M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$8.51M
2
A icon
Agilent Technologies
A
+$6.74M
3
GILD icon
Gilead Sciences
GILD
+$6.48M
4
RVTY icon
Revvity
RVTY
+$6.21M
5
AET
Aetna Inc
AET
+$6.01M

Sector Composition

Rank Sector Weight
1 Healthcare 92.73%
2 Financials 1.34%
3 Energy 1.14%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNH icon
1
UnitedHealth
UNH
$382B
$7.72M 2.86%
35,000
-10,000
-22% -$2.12M
MOH icon
2
Molina Healthcare
MOH
$10.4B
$7.67M 2.85%
100,000
+5,000
+5% +$361K
HCA icon
3
HCA Healthcare
HCA
$88.4B
$7.47M 2.77%
+85,000
New +$6.83M
CNC icon
4
Centene
CNC
$30.5B
$7.06M 2.62%
140,000
-20,000
-13% -$969K
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.04M 2.61%
35,000
-10,000
-22% -$1.94M
UHS icon
6
Universal Health Services
UHS
$10.2B
$6.8M 2.52%
+60,000
New +$6.41M
ELV icon
7
Elevance Health
ELV
$81.5B
$6.75M 2.51%
30,000
-7,500
-20% -$1.6M
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$123B
$6.74M 2.5%
45,000
-5,000
-10% -$740K
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$11.9B
$6.69M 2.48%
75,000
– –
INCY icon
10
Incyte
INCY
$25.8B
$6.63M 2.46%
70,000
+25,000
+56% +$2.61M
BAX icon
11
Baxter International
BAX
$12.8B
$6.46M 2.4%
100,000
-20,000
-17% -$1.28M
BIIB icon
12
Biogen
BIIB
$30.9B
$6.37M 2.36%
20,000
-2,500
-11% -$802K
ABBV icon
13
AbbVie
ABBV
$465B
$6.29M 2.33%
65,000
-30,000
-32% -$2.83M
ABT icon
14
Abbott
ABT
$187B
$6.28M 2.33%
110,000
-30,000
-21% -$1.66M
HUM icon
15
Humana
HUM
$43.9B
$6.2M 2.3%
25,000
-10,000
-29% -$2.47M
CI icon
16
Cigna
CI
$78.4B
$6.09M 2.26%
30,000
-5,000
-14% -$995K
COR icon
17
Cencora
COR
$62B
$5.51M 2.04%
60,000
+20,000
+50% +$1.65M
ZBH icon
18
Zimmer Biomet
ZBH
$18.8B
$5.43M 2.02%
46,350
+20,600
+80% +$2.33M
CELG
19
DELISTED
Celgene Corp
CELG
$5.22M 1.94%
50,000
-5,000
-9% -$564K
TEVA icon
20
Teva Pharmaceuticals
TEVA
$40.4B
$5.21M 1.93%
275,000
+175,000
+175% +$2.63M
ISRG icon
21
Intuitive Surgical
ISRG
$127B
$5.11M 1.9%
42,000
+12,750
+44% +$1.6M
VTRS icon
22
Viatris
VTRS
$20.8B
$5.08M 1.88%
+120,000
New +$4.59M
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
$4.78M 1.78%
40,000
-20,000
-33% -$2.44M
BSX icon
24
Boston Scientific
BSX
$68.4B
$4.71M 1.75%
190,000
-70,000
-27% -$1.93M
MCK icon
25
McKesson
MCK
$104B
$4.68M 1.74%
30,000
+5,000
+20% +$741K
1
2 3 4

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
FF
Fairway Financial Casselberry, Florida $132M AUM 13.23% 1-Year Est. Return
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM

Sivik Global Healthcare's Q4 2017 Portfolio in Review

As of Q4 2017, Sivik Global Healthcare held 93 positions worth $269M, down 8.3% from $294M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sivik Global Healthcare withdrew a net $35.3M in Q4 2017, closing 25 positions and reducing 26 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $8.51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 87% a quarter earlier, followed by Financials and Energy.

Against the trend, Sivik Global Healthcare opened a new position in HCA Healthcare worth $7.47M.

  • Sivik Global Healthcare's largest Q4 2017 buy was HCA Healthcare: 85,000 shares worth $7.47M.
  • Sivik Global Healthcare added most to Teva Pharmaceuticals in Q4 2017, an estimated $2.63M increase.
  • Sivik Global Healthcare's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $6.01M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q4 2017, selling an estimated $8.51M.
  • Sivik Global Healthcare's ten largest holdings make up 26% of its $269M portfolio in Q4 2017.
  • Sivik Global Healthcare opened 19 new positions and closed 25 in Q4 2017.
  • Sivik Global Healthcare's portfolio value fell 8.3% quarter-over-quarter to $269M.

Based on Sivik Global Healthcare's 13F filing for Q4 2017, filed 8 Feb 2018.